Table 2.

Patient's Comorbid, Kidney Profile, and Outcome of The Included Studies.

Author	Type of Donor (%)	Time from Transplant to COVID-19 (month)	BMI	Comorbid	Mortality Rate (%)
Craverdi, 2020	Deceased, 77.8	60 (24–111)	N/A	Hypertension Diabetes Obesity Hearth Disease Lung Disease Cancer Smoker (current/past) HIV/AIDS	31.94
Crespo, 2020	N/A	72 (31–145)	N/A		26.33
Azzi, 2020	Deceased, 73	58.2 (25.4–127.6)	28.5 (24.2–32.6)	Hypertension Diabetes mellitus Heart disease Lung disease Cancer History of smoking	20.52
Perez-Saez, 2020	N/A	72 (16.5–165)	N/A	Hypertension Diabetes mellitus Obesity (BMI > 30) Ischaemic heart disease Lung disease Cancer Smoking	32.5
Benotmane, 2020	N/A	79.2 (33.6–175.2)	29.5 (24–33)	Obesity (BMI >30) Hypertension Diabetes Obstructive sleep apnea Cardiovascular disease Respiratory disease Active cancer	N/A
Kute, 2021	Deceased, 9.6	42 (21.6–74.4)	N/A	Obesity (BMI >30) Hypertension Diabetes Heart disease Virus Infection (CMV/HCV/HBV) Prior Allograft dysfunction	11.6
Rahbar, 2020	Decease, 42.1	105.3 ± 75.4	N/A	Diabetes Hypertension	47.37
Cailard, 2020	N/A	74.1 (27.6–138.7)	N/A	Hypertension Diabetes Cardiovascular disease Respiratory disease Cancer Smoking	17.70
Santeusanio, 2020	Deceased, 55.3	69.6 (16.1–111.8)	28.3 ± 6.2	Hypertension Diabetes HIV/AIDS Interstitial lung disease Malignancy within 1 year Prior infection within 1 year Prior transplantation	28.95

N/A, not available; BMI, Body Mass Index. Data are expressed as mean ± standard deviation or median (min-max) or count %, as appropriate.